In last trading session, Wave Life Sciences Ltd. (NASDAQ:WVE) saw 0.37 million shares changing hands with its beta currently measuring -1.10. Company’s recent per share price level of $5.13 trading at -$0.1 or -1.91% at ring of the bell on the day assigns it a market valuation of $639.92M. That closing price of WVE’s stock is at a discount of -49.51% from its 52-week high price of $7.67 and is indicating a premium of 31.77% from its 52-week low price of $3.50. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.47 million shares which gives us an average trading volume of 874.01K if we extend that period to 3-months.
For Wave Life Sciences Ltd. (WVE), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.38. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Wave Life Sciences Ltd. (NASDAQ:WVE) trade information
Upright in the red during last session for losing -1.91%, in the last five days WVE remained trading in the red while hitting it’s week-highest on Tuesday, 09/03/24 when the stock touched $5.13 price level, adding 12.31% to its value on the day. Wave Life Sciences Ltd.’s shares saw a change of 1.58% in year-to-date performance and have moved -10.16% in past 5-day. Wave Life Sciences Ltd. (NASDAQ:WVE) showed a performance of -14.21% in past 30-days. Number of shares sold short was 3.35 million shares which calculate 4.73 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 14 to the stock, which implies a rise of 63.36% to its current value. Analysts have been projecting 11 as a low price target for the stock while placing it at a high target of 17. It follows that stock’s current price would drop -114.42% in reaching the projected high whereas dropping to the targeted low would mean a loss of -114.42% for stock’s current value.
Wave Life Sciences Ltd. (WVE) estimates and forecasts
Statistics highlight that Wave Life Sciences Ltd. is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -24.78% of value to its shares in past 6 months, showing an annual growth rate of -94.44% while that of industry is 17.90. Apart from that, the company came lowering its revenue forecast for fiscal year 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 36.03% during past 5 years.
Wave Life Sciences Ltd. (NASDAQ:WVE)’s Major holders
Insiders are in possession of 16.25% of company’s total shares while institution are holding 75.52 percent of that, with stock having share float percentage of 90.18%. Investors also watch the number of corporate investors in a company very closely, which is 75.52% institutions for Wave Life Sciences Ltd. that are currently holding shares of the company. RA CAPITAL MANAGEMENT, L.P. is the top institutional holder at WVE for having 18.2 million shares of worth $90.83 million. And as of 2024-06-30, it was holding 14.0527 of the company’s outstanding shares.
The second largest institutional holder is MAVERICK CAPITAL LTD, which was holding about 7.67 million shares on 2024-06-30. The number of shares represents firm’s hold over 5.9211 of outstanding shares, having a total worth of $38.27 million.
